CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
about
sameAs
Cannabis and psychosis/schizophrenia: human studiesGene-environment interplay between cannabis and psychosisThe endocannabinoid system as an emerging target of pharmacotherapySeasonal correlation of sporadic schizophrenia to Ixodes ticks and Lyme borreliosisEndocannabinoid signalling in the blood of patients with schizophreniaCannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia PharmacotherapyCannabis and schizophrenia: towards a cannabinoid hypothesis of schizophreniaThe Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisSocial Stress and Psychosis Risk: Common Neurochemical Substrates?The role of cannabinoid 1 receptor expressing interneurons in behavior.Long-term consequences of adolescent cannabinoid exposure in adult psychopathology.Sensory gating impairments in heavy cannabis users are associated with altered neural oscillations.Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice.Cognitive control deficits in schizophrenia: mechanisms and meaningImpaired fear memory specificity associated with deficient endocannabinoid-dependent long-term plasticity.Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuseVulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.Transcription of AAT•ATT triplet repeats in Escherichia coli is silenced by H-NS and IS1E transposition.Targeting the endocannabinoid system in Alzheimer's disease.Cannabis and psychosis: what is the link?Interpreting the association between cannabis use and increased risk for schizophreniaCannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.Pharmacogenetics of new analgesics.Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.Cannabinoid receptors: nomenclature and pharmacological principlesCannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbensCannabinoids and Schizophrenia: Risks and Therapeutic PotentialConvergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data.Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders.Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.Endocannabinoid system: potential novel targets for treatment of schizophrenia.Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.Cannabis, cannabinoids and schizophrenia: integration of the evidence.Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder.Large-scale molecular analysis of a 34 Mb interval on chromosome 6q: major refinement of the RP25 interval.
P2860
Q24628837-53A94FA6-FFD5-484C-AEF1-7605D8EA0FC7Q24643510-265C004F-28BD-45C9-8023-62B0E115B039Q24648473-41E1DC58-F2FA-4CBB-B02D-34847614C319Q24799626-26F7568D-66A4-4DD8-94B2-EA9CF09C8F8DQ24800061-A01D23BA-6927-47A1-9780-06680629C24DQ28078534-28412971-2916-43B5-9596-A4D3C5B52792Q28285577-6793877E-F609-4E38-AE09-A3FBA4551827Q30047193-9CF0ACEE-278B-4471-B2CC-3D70377B6176Q30364687-3264D4CC-81A8-43AD-9784-5A4B2B41B7B9Q30417825-FB407C28-59DD-4A75-B410-A4C31C69AD94Q30424669-464A43EE-C141-4D6C-947E-13E3A84A96D3Q30459343-C0FF4636-7E64-4D8A-B776-42E567973B8BQ30467877-9FDCEF08-8440-4B3D-880B-DD3F2F5FCB50Q30476447-1F6E778C-2BFB-4D2D-BEDE-AF040E6039D8Q30578265-FC0F34F4-5230-424E-B187-4F9317CC00DEQ31095554-18764BB0-9D77-4FD9-A83E-B139CDE98461Q33293523-220773DE-2186-4700-89FC-BE10EA420949Q33535863-1E3BFB50-E873-400C-BD5D-73721E9552F7Q33590705-DE10E7BF-D082-4B63-90F8-650FB769D0C5Q33664684-4147FD12-EAA1-41EA-BE77-D405316AE533Q33769087-C6B467DC-5470-48AE-AAB1-4194DF52AA39Q33930000-55B0ADDF-E862-4970-8BE1-2DDF9D34210FQ34005782-2ADB0A3B-81E1-4E66-ACE9-B6F3EA561C62Q34439127-8BD4A288-9E37-414B-9267-B40CA6F19BCEQ34899462-1219E852-1916-48AF-B1BF-B2A614CCFC15Q35005640-7AB7D335-CEA8-4306-BAE2-389CFDB49D13Q35784024-96773B8A-D4AC-474E-AF1E-CE1632CCF0F2Q36044310-DE1D3F69-59DC-4E66-9C06-4D9969AA3A0BQ36083621-CACFC77F-7525-4078-97B0-82600DF00564Q36157669-77BF9FEB-0E67-4A82-B639-BB71C14CF92AQ36189837-7C1A66B9-FA45-4213-A6DF-C0A67018661BQ36252902-E0815719-01F2-4B91-9FE5-7F9C01FB6E28Q36425951-82E0720E-30D5-44B2-955E-6D9AD416D384Q36612284-5BB0773F-F10B-42B9-A259-AEE19FD4C0BAQ36675661-A7FCBB6E-5DBF-4631-A9CA-44B492A220D3Q37015433-F48CEEEE-95E9-4A92-B817-796B854F47B4Q37030178-5F663ECD-023E-4D9C-B870-0817C82DAB1DQ37160448-141FE27C-7A08-4DB6-9A3D-DF044A3F5EE1Q37200559-D71F2375-AA39-45C6-924F-0E562705964BQ37209288-26C4B338-62FC-4593-8204-0478E7068C20
P2860
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@ast
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@en
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@nl
type
label
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@ast
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@en
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@nl
prefLabel
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@ast
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@en
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
CNR1, central cannabinoid rece ...... y to hebephrenic schizophrenia
@en
P2093
Y Fujiwara
P2860
P2888
P3181
P356
10.1038/SJ.MP.4001029
P407
P577
2002-01-01T00:00:00Z